Frank Rimerman Advisors LLC Sells 8,150 Shares of Altria Group, Inc. $MO

Frank Rimerman Advisors LLC lessened its position in Altria Group, Inc. (NYSE:MO) by 11.8% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 60,847 shares of the company’s stock after selling 8,150 shares during the quarter. Frank Rimerman Advisors LLC’s holdings in Altria Group were worth $3,508,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other large investors have also added to or reduced their stakes in the company. Darwin Wealth Management LLC bought a new stake in Altria Group during the second quarter worth about $27,000. EMC Capital Management purchased a new position in shares of Altria Group during the 3rd quarter valued at about $33,000. Gould Capital LLC purchased a new position in shares of Altria Group during the 3rd quarter valued at about $39,000. Elevation Wealth Partners LLC lifted its position in Altria Group by 79.0% in the 4th quarter. Elevation Wealth Partners LLC now owns 630 shares of the company’s stock worth $36,000 after buying an additional 278 shares during the last quarter. Finally, Physician Wealth Advisors Inc. lifted its position in Altria Group by 634.5% in the 3rd quarter. Physician Wealth Advisors Inc. now owns 639 shares of the company’s stock worth $42,000 after buying an additional 552 shares during the last quarter. Hedge funds and other institutional investors own 57.41% of the company’s stock.

Analysts Set New Price Targets

A number of brokerages have commented on MO. Argus upgraded shares of Altria Group to a “hold” rating in a research report on Tuesday, January 13th. Stifel Nicolaus lowered their price objective on shares of Altria Group from $72.00 to $68.00 and set a “buy” rating for the company in a report on Friday, January 30th. Citigroup upped their price objective on shares of Altria Group from $57.00 to $65.00 and gave the company a “neutral” rating in a research note on Monday, February 9th. Jefferies Financial Group increased their target price on shares of Altria Group from $47.00 to $50.00 and gave the company an “underperform” rating in a report on Wednesday, March 4th. Finally, UBS Group lifted their target price on shares of Altria Group from $67.00 to $74.00 and gave the stock a “buy” rating in a research report on Monday, March 9th. Five research analysts have rated the stock with a Buy rating, four have issued a Hold rating and two have issued a Sell rating to the company’s stock. According to MarketBeat, the stock presently has a consensus rating of “Hold” and an average price target of $65.75.

Key Headlines Impacting Altria Group

Here are the key news stories impacting Altria Group this week:

• Positive Sentiment: FDA pilot authorization and national rollout of on! PLUS nicotine pouches positions Altria in regulated, smoke‑free oral nicotine growth channels — a potential long‑term revenue diversification catalyst. FDA Pilot Approval of on! PLUS Nicotine Pouches Could Be A Game Changer For Altria Group (MO)
• Positive Sentiment: Altria is expanding retail distribution of on! PLUS, supporting near‑term sales momentum for its smoke‑free product push. Altria Group Expands Distribution of on! Plus Nicotine Pouch
• Positive Sentiment: Technical/relative strength signals: Altria earned an 81 RS rating in a recent screen, which can attract momentum and income‑focused buyers. Stocks showing rising market leadership: Altria Group earns 81 RS rating
• Positive Sentiment: Dividend appeal remains strong — coverage in income/dividend screens and commentary about Altria’s high yield supports investor interest in the name as a defensive income stock. Up More Than 12% This Year, Is This Dividend Stock With an Ultra-High Yield a No-Brainer Buy?
• Neutral Sentiment: Valuation debates: analysts and commentary are re‑assessing MO’s valuation now that on! PLUS is nationwide; some see a valuation discount driven by legal and category competition risk. Assessing Altria Group’s (MO) Valuation As On! PLUS Nicotine Pouches Roll Out Nationwide
• Negative Sentiment: Major legal overhang: a federal judge allowed antitrust class actions tied to Altria’s past Juul investment to proceed to trial, broadening potential damages exposure and investor uncertainty. This is the primary near‑term negative catalyst pressuring the stock. Altria Faces Juul Antitrust Trials As Valuation Discount Draws Attention
• Negative Sentiment: Underperformance vs. peers and commentary on long‑term product diversification risk (on! still faces stiff competition) add to caution among some investors. Altria Group Inc. stock underperforms Tuesday when compared to competitors The Major Long-Term Risk Facing Altria Stock in 2026

Altria Group Price Performance

Shares of MO stock opened at $65.95 on Wednesday. The stock has a market capitalization of $110.27 billion, a PE ratio of 16.05, a P/E/G ratio of 2.86 and a beta of 0.45. Altria Group, Inc. has a 1-year low of $52.82 and a 1-year high of $70.51. The business has a 50-day moving average of $65.80 and a 200 day moving average of $62.49.

Altria Group (NYSE:MO) last announced its quarterly earnings results on Thursday, January 29th. The company reported $1.30 EPS for the quarter, missing analysts’ consensus estimates of $1.32 by ($0.02). Altria Group had a negative return on equity of 287.61% and a net margin of 29.84%.The company had revenue of $5.08 billion during the quarter, compared to analysts’ expectations of $5.02 billion. During the same period last year, the firm earned $1.30 earnings per share. Altria Group’s revenue for the quarter was down .5% on a year-over-year basis. Analysts anticipate that Altria Group, Inc. will post 5.32 EPS for the current year.

Altria Group Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Thursday, April 30th. Investors of record on Wednesday, March 25th will be paid a $1.06 dividend. This represents a $4.24 annualized dividend and a dividend yield of 6.4%. The ex-dividend date of this dividend is Wednesday, March 25th. Altria Group’s payout ratio is presently 103.16%.

Insider Buying and Selling

In related news, SVP Charles N. Whitaker sold 27,908 shares of the company’s stock in a transaction on Thursday, March 5th. The shares were sold at an average price of $67.57, for a total transaction of $1,885,743.56. Following the completion of the sale, the senior vice president directly owned 180,869 shares in the company, valued at $12,221,318.33. This represents a 13.37% decrease in their position. The transaction was disclosed in a filing with the SEC, which is available through this link. 0.08% of the stock is owned by corporate insiders.

Altria Group Profile

Altria Group, Inc (NYSE: MO) is a U.S.-based consumer goods company whose principal business is the manufacture and sale of tobacco products. Headquartered in Richmond, Virginia, the company’s operations are focused primarily on the U.S. market and include the production, marketing and distribution of cigarettes, smokeless tobacco and cigars. Its flagship cigarette franchise in the United States is sold through its operating subsidiaries and is among the most recognizable cigarette brands in the country.

Altria’s principal operating businesses include Philip Morris USA (cigarettes), U.S.